Developer docs
API playgroundTry for free, no card

Search company profiles

BBK Worldwide

Full company profile

uuid0006fpa

Namestring
BBK Worldwide
Legal namestring
BBK Worldwide, LLC
Company typeenum
Private
Founded yearint
1983
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNeedham, United States
HQ citystring
Needham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial recruitment, patient engagement services, decentralized clinical trials, trial site support, patient recruitment technology
Industry3 codes
PRIMARYHLAGACAD
Clinical Trial Patient Recruitment & Retention
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
SECONDARYMPAAAFAM
B2B / Account-Based Marketing (ABM) Strategy Consulting
NAICS code2 codes
  • Marketing Consulting Services541613
  • Management Consulting Services54161
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Health Services8000
Product category
Clinical Trial Patient Recruitment Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Patient Recruitment Services
TypeProfessional Services
Description

BBK Worldwide provides comprehensive patient recruitment services including strategy and research, creative services, outreach services, and site success services to clinical trial sponsors. Revenue is generated through service fees for patient enrollment and engagement campaigns.

bbkworldwide.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Marketing or Sales, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1TrialCentralNet
Description

Proprietary technology platform powering BBK's patient recruitment and engagement services.

bbkworldwide.com
Core offering1 text field

BBK Worldwide provides patient recruitment and engagement services to clinical trial sponsors, including pharmaceutical companies, biotechnology firms, and Contract Research Organizations. Its integrated offering spans strategy and research, creative campaign development, multi-channel outreach, site success support, participant travel, participant payments, decentralized at-home services, and a patient engagement platform, all powered by its proprietary TrialCentralNet® technology platform. Services are delivered through a hybrid approach that supports traditional site-based, virtual, and decentralized clinical trials globally.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

BBK Worldwide offers a hybrid approach to clinical trial patient recruitment and engagement as a unified platform-plus-services architecture. The core proprietary technology, TrialCentralNet®, powers an integrated suite of services that can be customized by patient or site for traditional site-based, virtual, or decentralized trials. Services span recruitment (Strategy & Research, Creative Services, Outreach Services, Site Success Services), engagement (Participant Travel, Participant Payments, Decentralized Services, Patient Engagement Platform), and technology, enabling sponsors to flexibly configure solutions across traditional, virtual, or hybrid trial modalities.

Product and service9 records
1TrialCentralNet®
CategoryProprietary Technology Platform
Description

Proprietary technology platform that powers BBK Worldwide's full spectrum of patient recruitment and engagement services, providing clinical trial sponsors with integrated, strategically effective, and responsive solutions.

2Strategy & Research
3Creative Services
4Outreach Services
5Site Success Services
6Participant Travel
7Participant Payments
8Decentralized Services
9Patient Engagement Platform
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeOthers
Description

BBK Worldwide is a member company of Publicis Health, operating as a subsidiary within the Publicis Groupe healthcare communications network. This provides BBK with access to broader healthcare industry resources and integration within a major healthcare communications organization.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

BBK Worldwide and Langland U.S. merged operations to form Heartbeat Clinical Research, combining BBK's patient recruitment and engagement capabilities with Langland's clinical research expertise to create an integrated patient activation approach.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeDirect peer
Description

Antidote is a digital patient recruitment company that matches patients to clinical trials through technology-driven outreach and a network of partner sites. It directly competes with BBK in patient recruitment and trial awareness, particularly for sponsor-led campaigns seeking tech-forward enrollment.

TypeEmerging player
Description

SubjectWell is a patient recruitment platform that uses a marketplace model to connect clinical trial sponsors with prospective patients via consumer media channels. It overlaps with BBK's Outreach Services and Patient Engagement Platform, though it is more tech-native and self-serve.

TypeDirect peer
Description

Clinical Trial Media is a patient recruitment agency focused on media-driven outreach for clinical trial sponsors, comparable to BBK's Outreach and Creative Services. Both firms compete for sponsor advertising budgets to accelerate trial enrollment.

TypeBroad incumbent
Description

Acurian, now part of PPD (Thermo Fisher Scientific), is a long-established patient recruitment and retention provider. It competes with BBK directly on recruitment services but also benefits from being embedded in a global CRO, giving it broader sponsor access.

TypeBroad incumbent
Description

IQVIA is a global CRO and life sciences services firm with patient recruitment and engagement offerings integrated into its full-service trial delivery. It competes with BBK both as a sponsor of dedicated recruitment engagements and through bundled CRO contracts.

TypeBroad incumbent
Description

Syneos Health is a biopharma solutions organization offering clinical development and commercialization services, including patient recruitment capabilities. It is comparable to BBK as a sponsor-facing recruitment provider, but as part of a much broader CRO and commercialization portfolio.

TypeDirect peer
Description

Praxis Communications provides patient recruitment, retention, and engagement services for clinical trials, with a focus on therapeutic-area expertise and site support. It is comparable to BBK's Site Success and recruitment service lines targeting pharma and biotech sponsors.

TypeDirect peer
Description

ICTS is a patient recruitment and retention agency serving pharmaceutical, biotech, and CRO clients. It competes with BBK across outreach, site engagement, and patient engagement services for clinical trial enrollment.

9Deep 6 AI
TypeEmerging player
Description

Deep 6 AI uses artificial intelligence and real-world data to accelerate clinical trial patient recruitment by mining EHR and structured medical records. It is a tech-forward emerging player overlapping with BBK's recruitment analytics and outreach offerings.

TypeOthers
Description

Langland is a healthcare advertising and communications agency under Publicis Health that merged with BBK Worldwide to form Heartbeat Clinical Research. It is now a sister entity and former operational partner, sharing the same parent and overlapping in clinical trial communications.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BBK Worldwide

Clinical Trial Patient Recruitment Servicesbbkworldwide.com

BBK Worldwide firmographics

Firmographics
Name
BBK Worldwide
Legal name
BBK Worldwide, LLC
Website
https://bbkworldwide.com
Company type
Private
Founded year
1983
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

BBK Worldwide industry classification

Industry
Product category
Clinical Trial Patient Recruitment Services
NAICS
Marketing Consulting Services (541613), Management Consulting Services (54161)
SIC
Services-Management Consulting Services (8742), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGACAD
Clinical Trial Patient Recruitment & Retention
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
SECONDARYMPAAAFAM
B2B / Account-Based Marketing (ABM) Strategy Consulting

Keywords

  • Clinical trial recruitment
  • Patient engagement services
  • Decentralized clinical trials
  • Trial site support
  • Patient recruitment technology

Where BBK Worldwide is headquartered

Location

Headquarters

HQ city
Needham
HQ country
United States
HQ region
North America

Offices1 record

Markets served

BBK Worldwide business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

  1. Patient Recruitment Services: BBK Worldwide provides comprehensive patient recruitment services including strategy and research, creative services, outreach services, and site success services to clinical trial sponsors. Revenue is generated through service fees for patient enrollment and engagement campaigns.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

BBK Worldwide product offering

Product offering

Core offering

BBK Worldwide provides patient recruitment and engagement services to clinical trial sponsors, including pharmaceutical companies, biotechnology firms, and Contract Research Organizations. Its integrated offering spans strategy and research, creative campaign development, multi-channel outreach, site success support, participant travel, participant payments, decentralized at-home services, and a patient engagement platform, all powered by its proprietary TrialCentralNet® technology platform. Services are delivered through a hybrid approach that supports traditional site-based, virtual, and decentralized clinical trials globally.

Product overview

BBK Worldwide offers a hybrid approach to clinical trial patient recruitment and engagement as a unified platform-plus-services architecture. The core proprietary technology, TrialCentralNet®, powers an integrated suite of services that can be customized by patient or site for traditional site-based, virtual, or decentralized trials. Services span recruitment (Strategy & Research, Creative Services, Outreach Services, Site Success Services), engagement (Participant Travel, Participant Payments, Decentralized Services, Patient Engagement Platform), and technology, enabling sponsors to flexibly configure solutions across traditional, virtual, or hybrid trial modalities.

Differentiator

Problem solved

Functional benefit

Brands

  • TrialCentralNet: Proprietary technology platform powering BBK's patient recruitment and engagement services.

Products and services

  • TrialCentralNet® Proprietary technology platform that powers BBK Worldwide's full spectrum of patient recruitment and engagement services, providing clinical trial sponsors with integrated, strategically effective, and responsive solutions.
  • Strategy & Research
  • Creative Services
  • Outreach Services
  • Site Success Services
  • Participant Travel
  • Participant Payments
  • Decentralized Services
  • Patient Engagement Platform

Companies that use BBK Worldwide

Customer profile

Segments1 record

Ideal customer profiles1 record

BBK Worldwide technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

BBK Worldwide partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Publicis HealthcoreOthersBBK Worldwide is a member company of Publicis Health, operating as a subsidiary within the Publicis Groupe healthcare communications network. This provides BBK with access to broader healthcare industry resources and integration within a major healthcare communications organization.
  • Langland U.S.coreStrategic or Co-development PartnerBBK Worldwide and Langland U.S. merged operations to form Heartbeat Clinical Research, combining BBK's patient recruitment and engagement capabilities with Langland's clinical research expertise to create an integrated patient activation approach.

Scale indicators2 records

Recent moves5 records

BBK Worldwide competitors and assessment

Company assessment

Direct peers

  • Antidote: Antidote is a digital patient recruitment company that matches patients to clinical trials through technology-driven outreach and a network of partner sites. It directly competes with BBK in patient recruitment and trial awareness, particularly for sponsor-led campaigns seeking tech-forward enrollment.
  • Clinical Trial Media: Clinical Trial Media is a patient recruitment agency focused on media-driven outreach for clinical trial sponsors, comparable to BBK's Outreach and Creative Services. Both firms compete for sponsor advertising budgets to accelerate trial enrollment.
  • Praxis Communications: Praxis Communications provides patient recruitment, retention, and engagement services for clinical trials, with a focus on therapeutic-area expertise and site support. It is comparable to BBK's Site Success and recruitment service lines targeting pharma and biotech sponsors.
  • Integrated Clinical Trial Services (ICTS): ICTS is a patient recruitment and retention agency serving pharmaceutical, biotech, and CRO clients. It competes with BBK across outreach, site engagement, and patient engagement services for clinical trial enrollment.

Emerging players

  • SubjectWell: SubjectWell is a patient recruitment platform that uses a marketplace model to connect clinical trial sponsors with prospective patients via consumer media channels. It overlaps with BBK's Outreach Services and Patient Engagement Platform, though it is more tech-native and self-serve.
  • Deep 6 AI: Deep 6 AI uses artificial intelligence and real-world data to accelerate clinical trial patient recruitment by mining EHR and structured medical records. It is a tech-forward emerging player overlapping with BBK's recruitment analytics and outreach offerings.

Broad incumbents

  • Acurian (PPD / Thermo Fisher): Acurian, now part of PPD (Thermo Fisher Scientific), is a long-established patient recruitment and retention provider. It competes with BBK directly on recruitment services but also benefits from being embedded in a global CRO, giving it broader sponsor access.
  • IQVIA: IQVIA is a global CRO and life sciences services firm with patient recruitment and engagement offerings integrated into its full-service trial delivery. It competes with BBK both as a sponsor of dedicated recruitment engagements and through bundled CRO contracts.
  • Syneos Health: Syneos Health is a biopharma solutions organization offering clinical development and commercialization services, including patient recruitment capabilities. It is comparable to BBK as a sponsor-facing recruitment provider, but as part of a much broader CRO and commercialization portfolio.

Others

  • Langland (Publicis Health): Langland is a healthcare advertising and communications agency under Publicis Health that merged with BBK Worldwide to form Heartbeat Clinical Research. It is now a sister entity and former operational partner, sharing the same parent and overlapping in clinical trial communications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

BBK Worldwide social profiles

Digital presence

BBK Worldwide financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BBK Worldwide leadership team

Management profile

Number of profiles

Profiles1 record

BBK Worldwide funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BBK Worldwide M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BBK Worldwide

What does BBK Worldwide do?

BBK Worldwide provides patient recruitment and engagement services to clinical trial sponsors, including pharmaceutical companies, biotechnology firms, and Contract Research Organizations. Its integrated offering spans strategy and research, creative campaign development, multi-channel outreach, site success support, participant travel, participant payments, decentralized at-home services, and a patient engagement platform, all powered by its proprietary TrialCentralNet® technology platform. Services are delivered through a hybrid approach that supports traditional site-based, virtual, and decentralized clinical trials globally.

Is BBK Worldwide a public or private company?

BBK Worldwide is a private company. It is classified as corporate owned and is currently operating.

When was BBK Worldwide founded?

BBK Worldwide was founded in 1983. It employs 101 to 250 people.

Where is BBK Worldwide based?

BBK Worldwide is headquartered in Needham, United States, in the North America region.

How does BBK Worldwide make money?

One revenue line is on record: patient Recruitment Services.

Who are BBK Worldwide's main competitors?

Direct peers on record are Antidote, Clinical Trial Media, Praxis Communications and Integrated Clinical Trial Services (ICTS). Emerging players are SubjectWell and Deep 6 AI. Broad incumbents are Acurian (PPD / Thermo Fisher), IQVIA and Syneos Health. Langland (Publicis Health) is listed as an others.

Does BBK Worldwide have an API?

No public API is recorded for BBK Worldwide.

What industry is BBK Worldwide in?

BBK Worldwide's product category is Clinical Trial Patient Recruitment Services. Its primary akta.pro industry code is HLAGACAD, Clinical Trial Patient Recruitment & Retention, with a secondary code of HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 541613 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Roots AnalysisTop 10 Clinical Trial Patient Recruitment Service ProvidersRoots Analysis published a report identifying ten leading clinical trial patient recruitment service providers, including BBK Worldwide, Clariness, and CMIC. The article highlights that these firms utilize advanced technologies like social media, Electronic Health Records, and proprietary platforms to address the high costs and delays associated with patient enrollment in drug development.PR NewswireBBK Worldwide Launches TCN® Engage, a Disruptive Tech-Service Ecosystem for an Inclusive and Positive Clinical Trial ExperienceBBK Worldwide announced the launch of TCN Engage, a comprehensive patient engagement ecosystem for clinical trials that consolidates visit support services from initial patient response through study completion, including recruitment, reimbursement, travel arrangements, interpreters, and home health services. The platform addresses a long-standing industry problem where clinically burdened and portal-fatigued staff lacked resources for effective patient enrollment, enabling sponsors to better support study staff who in turn support patients. TCN Engage is GDPR compliant, validated against predicate rules, adheres to US privacy laws, and offers API integration capabilities.PR NewswireBBK Worldwide's Clinical Cuisine™ Named One of the Most Innovative Products of the Year by PM360 MagazineBBK Worldwide announced that its Clinical Cuisine™ service was named one of the most innovative products of 2022 by PM360 Magazine. The service provides meal preparation and delivery for clinical trial participants and caregivers to support engagement during trials. This recognition highlights BBK's role in advancing patient support solutions within the healthcare industry.PR NewswireGlobal Patient Recruitment Services and Patient Retention Services Market Report to 2035: Players Featured Include BBK Worldwide, Continuum Clinical, IQVIA, United BioSource and WCG ThreeWireThe report details the current landscape and future potential of the patient recruitment and retention services market from 2022 to 2035, highlighting significant factors affecting clinical trials. It notes that 80% of clinical trials face delays due to insufficient patient recruitment, underscoring the strategic necessity of enhancing patient outreach and retention strategies. The market is expected to grow steadily, particularly in Asia Pacific, driven by the complexities of drug development and increasing clinical trial activities.PR NewswirePUBLICIS HEALTH ACQUIRES BBK WORLDWIDEPublicis Health announced the acquisition of BBK Worldwide, a full-service R&D marketing firm specializing in clinical trial experience. This transaction integrates BBK's proprietary technology and patient-centric services with Publicis Health's existing capabilities to accelerate global drug development programs.GlobeNewswireCellectar Reports Financial Results for the Third Quarter 2021 and Provides a Corporate UpdateCellectar Biosciences reported Q3 2021 results, with a net loss of $5.8 million and cash of $40.3 million. The company also announced a $2 million NIH grant, a collaboration with BBK Worldwide, and a manufacturing agreement with Evergreen Theragnostics. It expects to fund clinical milestones into the second half of 2023.GlobeNewswireCellectar Announces Innovative Concierge Service for Patients Participating in Its Clinical StudiesCellectar announced a collaboration with BBK Worldwide to provide concierge services for patients in its clinical studies, including transportation and reimbursement assistance. The company is also developing a Patient Assistance Program for iopofosine, pending FDA approval. The WM study enrolls up to 50 patients, and a Phase 2 study is ongoing for multiple myeloma.PR NewswireBBK Worldwide Clinical Trial Travel Reaches 20,000 Completed TripsBBK Worldwide announced that its RSG Arrive travel program, launched in 2012, has achieved the milestone of 20,000 completed trips supporting clinical trial participants. The program removes barriers to participation by handling travel needs including ground transportation, hotel bookings, air travel, and visa procurement, and has been particularly valuable during COVID-19 for minimizing trial disruptions. The program has been implemented in 40 countries and supports both widespread diseases like diabetes and rare diseases like spinal muscular atrophy.PR NewswireBBK Worldwide Launches the Engagement Solution Center for Decentralized and Post-Marketing Clinical Trial SuccessBBK Worldwide announced the launch of its Engagement Solution Center on May 12, 2021, designed to support decentralized and post-marketing clinical trials by centralizing patient-visit support services including recruitment, screening, travel arrangements, reimbursement, interpreters, medication delivery, and digital tools. The center is managed through BBK's TrialCentralNet portal and aims to eliminate barriers to clinical trial participation while easing operational burdens for study sponsors. The company highlighted its claimed 96% success rate for difficult-to-enroll trials and emphasized the service's ability to provide customized, scalable solutions across diverse populations and disease states.PR NewswireBBK Worldwide Creative Director, Patient Experience and Engagement, Jessica Kim Named to PharmaVOICE 100BBK Worldwide announced that Creative Director Jessica Kim was named to PharmaVOICE magazine's annual PharmaVOICE 100 list, recognizing her as one of the 100 most inspiring people in the life sciences industry. Kim, a nine-year veteran at the company, was acknowledged for her creative leadership in patient experience and engagement, including transforming BBK's app platform and developing the Study-Life Balance concept to help patients integrate clinical trial participation into daily life. The recognition is part of an annual award program that nominations are submitted by thousands of PharmaVOICE readers throughout the year.